| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.882 | 0 | 0.882 | Electrolyte absorption antagonist | 0.752 0.001 DBMET00729 | ||
| 0.726 | 0.004 | 0.79 | Diuretic | 0.79 0.003 DBMET00729 | DBMET00729 | |
| 0.735 | 0.032 | 0.735 | DNA polymerase beta inhibitor | 0.235 0.202 DBMET00729 | ||
| 0.684 | 0.003 | 0.844 | Carbonic anhydrase XIII inhibitor | 0.844 0.002 DBMET00729 | DBMET00729 | |
| 0.693 | 0.036 | 0.693 | DNA directed DNA polymerase inhibitor | |||
| 0.638 | 0.019 | 0.638 | 15-Lipoxygenase inhibitor | 0.284 0.141 DBMET00729 | ||
| 0.659 | 0.041 | 0.659 | Alpha-glucosidase inhibitor | |||
| 0.59 | 0.003 | 0.833 | Carbonic anhydrase VI inhibitor | 0.833 0.002 DBMET00729 | DBMET00729 | |
| 0.633 | 0.048 | 0.633 | Beta lactamase inhibitor | |||
| 0.58 | 0.017 | 0.58 | Thioredoxin glutathione reductase inhibitor | |||
| 0.505 | 0.023 | 0.505 | Calpain 2 inhibitor | |||
| 0.489 | 0.022 | 0.489 | 12-Lipoxygenase inhibitor | 0.217 0.133 DBMET00729 | ||
| 0.438 | 0.043 | 0.438 | Thyroid hormone beta antagonist | |||
| 0.42 | 0.034 | 0.466 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.466 0.025 DBMET00729 | DBMET00729 | |
| 0.431 | 0.047 | 0.431 | Thyroid hormone antagonist | |||
| 0.416 | 0.045 | 0.809 | Aldehyde oxidase inhibitor | 0.809 0.004 DBMET00729 | DBMET00729 | |
| 0.366 | 0.014 | 0.366 | Mcl-1 antagonist | 0.314 0.021 DBMET00729 | ||
| 0.444 | 0.093 | 0.444 | Transcription factor inhibitor | |||
| 0.343 | 0.015 | 0.343 | DNA methyltransferase I inhibitor | |||
| 0.371 | 0.045 | 0.371 | Lipoxygenase inhibitor | 0.235 0.11 DBMET00729 | ||
| 0.316 | 0.004 | 0.459 | Carbonic anhydrase XII inhibitor | 0.459 0.004 DBMET00729 | DBMET00729 | |
| 0.322 | 0.013 | 0.322 | Amyloid beta precursor protein antagonist | 0.245 0.035 DBMET00729 | ||
| 0.324 | 0.025 | 0.345 | Dual specificity phosphatase 3 inhibitor | 0.345 0.021 DBMET00729 | DBMET00729 | |
| 0.315 | 0.024 | 0.315 | DNA methylase inhibitor | |||
| 0.307 | 0.028 | 0.307 | Dual specificity phosphatase inhibitor | 0.28 0.032 DBMET00729 | ||
| 0.28 | 0.004 | 0.448 | Carbonic anhydrase VB inhibitor | 0.448 0.002 DBMET00729 | DBMET00729 | |
| 0.286 | 0.009 | 0.912 | Carbonic anhydrase XV inhibitor | 0.912 0.002 DBMET00729 | DBMET00729 | |
| 0.285 | 0.014 | 0.297 | Alkaline phosphatase inhibitor | 0.297 0.012 DBMET00729 | DBMET00729 | |
| 0.317 | 0.046 | 0.317 | Transcription factor STAT3 inhibitor | 0.305 0.051 DBMET00729 | ||
| 0.273 | 0.004 | 0.432 | Carbonic anhydrase V inhibitor | 0.432 0.003 DBMET00729 | DBMET00729 | |
| 0.263 | 0.005 | 0.463 | Carbonic anhydrase inhibitor | 0.463 0.003 DBMET00729 | DBMET00729 | |
| 0.253 | 0.004 | 0.442 | Carbonic anhydrase VII inhibitor | 0.442 0.003 DBMET00729 | DBMET00729 | |
| 0.269 | 0.023 | 0.395 | Cyclooxygenase inhibitor | 0.395 0.008 DBMET00729 | DBMET00729 | |
| 0.251 | 0.02 | 0.347 | Cyclooxygenase 2 inhibitor | 0.347 0.009 DBMET00729 | DBMET00729 | |
| 0.232 | 0.004 | 0.359 | Carbonic anhydrase VA inhibitor | 0.359 0.003 DBMET00729 | DBMET00729 | |
| 0.232 | 0.005 | 0.437 | Carbonic anhydrase I inhibitor | 0.437 0.003 DBMET00729 | DBMET00729 | |
| 0.243 | 0.018 | 0.347 | Hexokinase inhibitor | 0.347 0.006 DBMET00729 | DBMET00729 | |
| 0.309 | 0.098 | 0.309 | Prostaglandin dehydrogenase inhibitor | |||
| 0.229 | 0.021 | 0.283 | Cyclin-dependent kinase 3 inhibitor | 0.283 0.011 DBMET00729 | DBMET00729 | |
| 0.209 | 0.005 | 0.409 | Carbonic anhydrase II inhibitor | 0.409 0.003 DBMET00729 | DBMET00729 | |
| 0.205 | 0.008 | 0.429 | Carbonic anhydrase IX inhibitor | 0.429 0.004 DBMET00729 | DBMET00729 | |
| 0.185 | 0.004 | 0.634 | Carbonic anhydrase XIV inhibitor | 0.634 0.002 DBMET00729 | DBMET00729 | |
| 0.161 | 0.004 | 0.303 | Carbonic anhydrase IV inhibitor | 0.303 0.003 DBMET00729 | DBMET00729 | |
| 0.152 | 0.019 | 0.155 | CC chemokine 6 receptor antagonist | 0.155 0.016 DBMET00729 | DBMET00729 | |
| 0.187 | 0.061 | 0.292 | Succinate dehydrogenase inhibitor | 0.292 0.012 DBMET00729 | DBMET00729 | |
| 0.198 | 0.073 | 0.477 | Non-steroidal antiinflammatory agent | 0.477 0.008 DBMET00729 | DBMET00729 | |
| 0.183 | 0.062 | 0.183 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.218 | 0.097 | 0.218 | Calpain inhibitor | |||
| 0.146 | 0.028 | 0.146 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.232 | 0.114 | 0.232 | Streptokinase A inhibitor | |||
| 0.145 | 0.03 | 0.598 | Carbonic anhydrase III inhibitor | 0.598 0.003 DBMET00729 | DBMET00729 | |
| 0.134 | 0.033 | 0.147 | Urease inhibitor | 0.147 0.025 DBMET00729 | DBMET00729 | |
| 0.159 | 0.07 | 0.207 | Protein-tyrosine phosphatase inhibitor | 0.207 0.044 DBMET00729 | DBMET00729 | |
| 0.208 | 0.127 | 0.281 | Transcription factor STAT inhibitor | 0.281 0.067 DBMET00729 | DBMET00729 | |
| 0.149 | 0.076 | 0.149 | Cytidine deaminase inhibitor | |||
| 0.227 | 0.154 | 0.316 | Sodium/bile acid cotransporter inhibitor | 0.316 0.065 DBMET00729 | DBMET00729 | |
| 0.136 | 0.066 | 0.341 | Cyclooxygenase 1 inhibitor | 0.341 0.01 DBMET00729 | DBMET00729 | |
| 0.079 | 0.009 | 0.079 | CXC chemokine 1 receptor antagonist | 0.061 0.021 DBMET00729 | ||
| 0.143 | 0.082 | 0.173 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.173 0.063 DBMET00729 | DBMET00729 | |
| 0.182 | 0.126 | 0.247 | Peptidyltransferase inhibitor | 0.247 0.053 DBMET00729 | DBMET00729 | |
| 0.268 | 0.214 | 0.268 | MAP kinase 1 inhibitor | |||
| 0.069 | 0.016 | 0.069 | Adenine nucleotide translocase inhibitor | 0.068 0.017 DBMET00729 | ||
| 0.077 | 0.031 | 0.139 | NMDA receptor agonist | 0.139 0.009 DBMET00729 | DBMET00729 | |
| 0.077 | 0.039 | 0.086 | ZAP-70 protein tyrosine kinase inhibitor | 0.086 0.027 DBMET00729 | DBMET00729 | |
| 0.043 | 0.007 | 0.043 | CXC chemokine 2 receptor antagonist | 0.025 0.02 DBMET00729 | ||
| 0.056 | 0.024 | 0.056 | Alpha 1b adrenoreceptor agonist | |||
| 0.092 | 0.062 | 0.092 | ABCA1 expression enhancer | 0.091 0.064 DBMET00729 | ||
| 0.047 | 0.027 | 0.047 | Dihydroorotase inhibitor | |||
| 0.067 | 0.047 | 0.07 | Sphingosine 1-phosphate receptor 4 agonist | 0.07 0.045 DBMET00729 | DBMET00729 | |
| 0.107 | 0.092 | 0.125 | M17 leucyl aminopeptidase inhibitor | 0.125 0.073 DBMET00729 | DBMET00729 | |
| 0.036 | 0.023 | 0.036 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET00729 | ||
| 0.186 | 0.178 | 0.335 | Cholesterol antagonist | 0.335 0.071 DBMET00729 | DBMET00729 | |
| 0.082 | 0.079 | 0.131 | Uric acid excretion stimulant | 0.131 0.032 DBMET00729 | DBMET00729 | |
| 0.144 | 0.142 | 0.161 | Insulin sensitizer | 0.161 0.119 DBMET00729 | DBMET00729 | |
| 0.018 | 0.018 | 0.037 | Kainate receptor 5 antagonist | 0.037 0.007 DBMET00729 | DBMET00729 | |
| 0.034 | 0.036 | 0.268 | Kainate receptor antagonist | 0.268 0.003 DBMET00729 | DBMET00729 | |
| 0.029 | 0.033 | 0.031 | Peroxisome proliferator-activated receptor delta antagonist | 0.031 0.028 DBMET00729 | DBMET00729 | |
| 0.056 | 0.063 | 0.104 | HIV-1 reverse transcriptase inhibitor | 0.104 0.029 DBMET00729 | DBMET00729 | |
| 0.106 | 0.115 | 0.115 | Protein kinase (CK1) gamma 1 inhibitor | 0.115 0.103 DBMET00729 | DBMET00729 | |
| 0.029 | 0.038 | 0.041 | Glutamate (mGluR4) agonist | 0.041 0.015 DBMET00729 | DBMET00729 | |
| 0.036 | 0.046 | 0.097 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.097 0.003 DBMET00729 | DBMET00729 | |
| 0.015 | 0.028 | 0.021 | Estrone sulfatase inhibitor | 0.021 0.016 DBMET00729 | DBMET00729 | |
| 0.039 | 0.054 | 0.059 | Carnitine palmitoyltransferase 1B inhibitor | 0.059 0.019 DBMET00729 | DBMET00729 | |
| 0.046 | 0.063 | 0.072 | NMDA receptor glycine site agonist | 0.072 0.035 DBMET00729 | DBMET00729 | |
| 0.026 | 0.043 | 0.035 | Nicotinic acid receptor 2 agonist | 0.035 0.025 DBMET00729 | DBMET00729 | |
| 0.033 | 0.05 | 0.054 | Glutamate (mGluR group III) agonist | 0.054 0.021 DBMET00729 | DBMET00729 | |
| 0.043 | 0.06 | 0.112 | Autotaxin inhibitor | 0.112 0.011 DBMET00729 | DBMET00729 | |
| 0.075 | 0.096 | 0.15 | DNA directed RNA polymerase inhibitor | 0.15 0.024 DBMET00729 | DBMET00729 | |
| 0.053 | 0.076 | 0.098 | Prostaglandin-E synthase inhibitor | 0.098 0.028 DBMET00729 | DBMET00729 | |
| 0.044 | 0.067 | 0.087 | Cyclin H inhibitor | 0.087 0.014 DBMET00729 | DBMET00729 | |
| 0.009 | 0.033 | 0.029 | Carbonic anhydrase VIII inhibitor | 0.029 0.004 DBMET00729 | DBMET00729 | |
| 0.009 | 0.033 | 0.029 | Carbonic anhydrase X inhibitor | 0.029 0.004 DBMET00729 | DBMET00729 | |
| 0.034 | 0.06 | 0.055 | Prostaglandin E2 antagonist | 0.055 0.031 DBMET00729 | DBMET00729 | |
| 0.078 | 0.106 | 0.116 | Protein-tyrosine phosphatase 1B inhibitor | 0.116 0.066 DBMET00729 | DBMET00729 | |
| 0.018 | 0.047 | 0.035 | Calcium-sensing receptor agonist | 0.035 0.009 DBMET00729 | DBMET00729 | |
| 0.027 | 0.058 | 0.059 | Integrin alpha2 antagonist | 0.059 0.007 DBMET00729 | DBMET00729 | |
| 0.13 | 0.163 | 0.182 | Focal adhesion kinase 2 inhibitor | 0.182 0.086 DBMET00729 | DBMET00729 | |
| 0.042 | 0.074 | 0.09 | Phosphodiesterase VII inhibitor | 0.09 0.018 DBMET00729 | DBMET00729 | |
| 0.006 | 0.039 | 0.02 | Carbonic anhydrase XI inhibitor | 0.02 0.004 DBMET00729 | DBMET00729 | |
| 0.069 | 0.103 | 0.147 | Triose-phosphate isomerase inhibitor | 0.147 0.021 DBMET00729 | DBMET00729 | |
| 0.017 | 0.052 | 0.028 | Glutamate (mGluR1) agonist | 0.028 0.012 DBMET00729 | DBMET00729 | |
| 0.025 | 0.061 | 0.1 | Dihydropteroate synthase inhibitor | 0.1 0.005 DBMET00729 | DBMET00729 | |
| 0.011 | 0.049 | 0.019 | CC chemokine 9 receptor antagonist | 0.019 0.008 DBMET00729 | DBMET00729 | |
| 0.03 | 0.07 | 0.068 | Prostaglandin antagonist | 0.068 0.028 DBMET00729 | DBMET00729 | |
| 0.011 | 0.054 | 0.018 | CC chemokine 10 receptor antagonist | 0.018 0.005 DBMET00729 | DBMET00729 | |
| 0.05 | 0.095 | 0.065 | Trypsin inhibitor | 0.065 0.038 DBMET00729 | DBMET00729 | |
| 0.015 | 0.063 | 0.029 | HCV NS5B polymerase inhibitor | 0.029 0.025 DBMET00729 | DBMET00729 | |
| 0.028 | 0.077 | 0.079 | Fructose-1,6-bisphosphatase inhibitor | 0.079 0.008 DBMET00729 | DBMET00729 | |
| 0.014 | 0.063 | 0.064 | Factor X inhibitor | 0.064 0.017 DBMET00729 | DBMET00729 | |
| 0.097 | 0.154 | 0.174 | Mannose-6-phosphate isomerase inhibitor | 0.174 0.046 DBMET00729 | DBMET00729 | |
| 0.036 | 0.093 | 0.055 | Carbonic anhydrase II stimulant | 0.055 0.03 DBMET00729 | DBMET00729 | |
| 0.016 | 0.079 | 0.045 | Integrin alpha2beta1 antagonist | 0.045 0.005 DBMET00729 | DBMET00729 | |
| 0.011 | 0.08 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.01 DBMET00729 | DBMET00729 | |
| 0.078 | 0.15 | 0.126 | CDK3/cyclin E inhibitor | 0.126 0.048 DBMET00729 | DBMET00729 | |
| 0.01 | 0.085 | 0.057 | AMPA 3 receptor antagonist | 0.057 0.007 DBMET00729 | DBMET00729 | |
| 0.026 | 0.102 | 0.055 | AICAR transformylase inhibitor | 0.055 0.018 DBMET00729 | DBMET00729 | |
| 0.05 | 0.126 | 0.163 | Cyclin-dependent kinase 1 inhibitor | 0.163 0.036 DBMET00729 | DBMET00729 | |
| 0.032 | 0.11 | 0.061 | Phosphodiesterase 7A inhibitor | 0.061 0.02 DBMET00729 | DBMET00729 | |
| 0.005 | 0.087 | 0.093 | AMPA 1 receptor antagonist | 0.093 0.006 DBMET00729 | DBMET00729 | |
| 0.059 | 0.141 | 0.161 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.161 0.024 DBMET00729 | DBMET00729 | |
| 0.01 | 0.093 | 0.038 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.038 0.005 DBMET00729 | DBMET00729 | |
| 0.109 | 0.198 | 0.163 | MAP kinase kinase 4 inhibitor | 0.163 0.041 DBMET00729 | DBMET00729 | |
| 0.059 | 0.149 | 0.178 | Ferrochelatase inhibitor | 0.178 0.028 DBMET00729 | DBMET00729 | |
| 0.03 | 0.125 | 0.075 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.075 0.027 DBMET00729 | DBMET00729 | |
| 0.014 | 0.113 | 0.037 | ATP citrate lysase inhibitor | 0.037 0.015 DBMET00729 | DBMET00729 | |
| 0.017 | 0.119 | 0.041 | Phosphorylase inhibitor | 0.041 0.036 DBMET00729 | DBMET00729 | |
| 0.011 | 0.117 | 0.033 | LFA antagonist | 0.033 0.012 DBMET00729 | DBMET00729 | |
| 0.054 | 0.162 | 0.127 | UDP-glucose 4-epimerase inhibitor | 0.127 0.039 DBMET00729 | DBMET00729 | |
| 0.087 | 0.197 | 0.176 | Aryl hydrocarbon receptor agonist | 0.176 0.117 DBMET00729 | DBMET00729 | |
| 0.041 | 0.154 | 0.135 | Glutamate dehydrogenase inhibitor | 0.135 0.019 DBMET00729 | DBMET00729 | |
| 0.065 | 0.179 | 0.149 | Alpha-N-acetylglucosaminidase inhibitor | 0.149 0.056 DBMET00729 | DBMET00729 | |
| 0.039 | 0.16 | 0.1 | I kappa B kinase 1 inhibitor | 0.1 0.022 DBMET00729 | DBMET00729 | |
| 0.039 | 0.162 | 0.094 | GABA aminotransferase inhibitor | 0.094 0.032 DBMET00729 | DBMET00729 | |
| 0.065 | 0.188 | 0.161 | Adenylate kinase inhibitor | 0.161 0.023 DBMET00729 | DBMET00729 | |
| 0.054 | 0.177 | 0.157 | NADH dehydrogenase inhibitor | 0.157 0.016 DBMET00729 | DBMET00729 | |
| 0.01 | 0.134 | 0.035 | Urate transporter 1 inhibitor | 0.035 0.032 DBMET00729 | DBMET00729 | |
| 0.095 | 0.224 | 0.14 | Pregnane X receptor agonist | 0.14 0.075 DBMET00729 | DBMET00729 | |
| 0.05 | 0.18 | 0.2 | GABA C receptor agonist | 0.2 0.02 DBMET00729 | DBMET00729 | |
| 0.029 | 0.159 | 0.131 | Histidine decarboxylase inhibitor | 0.131 0.023 DBMET00729 | DBMET00729 | |
| 0.029 | 0.163 | 0.134 | Porphobilinogen synthase inhibitor | 0.134 0.024 DBMET00729 | DBMET00729 | |
| 0.024 | 0.159 | 0.051 | Purinergic P2X4 antagonist | 0.051 0.023 DBMET00729 | DBMET00729 | |
| 0.005 | 0.141 | 0.022 | NMDA receptor glycine site antagonist | 0.022 0.02 DBMET00729 | DBMET00729 | |
| 0.042 | 0.179 | 0.107 | Chemokine receptor antagonist | 0.107 0.057 DBMET00729 | DBMET00729 | |
| 0.039 | 0.178 | 0.083 | Ca(v)2.2 blocker | 0.083 0.062 DBMET00729 | DBMET00729 | |
| 0.013 | 0.152 | 0.154 | AMPA receptor antagonist | 0.154 0.005 DBMET00729 | DBMET00729 | |
| 0.023 | 0.164 | 0.053 | Kainate receptor agonist | 0.053 0.011 DBMET00729 | DBMET00729 | |
| 0.006 | 0.155 | 0.064 | Kynurenine 3 monooxygenase inhibitor | 0.064 0.005 DBMET00729 | DBMET00729 | |
| 0.044 | 0.193 | 0.109 | Cyclin-dependent kinase 2 inhibitor | 0.109 0.061 DBMET00729 | DBMET00729 | |
| 0.085 | 0.24 | 0.196 | I kappa B kinase epsilon inhibitor | 0.196 0.074 DBMET00729 | DBMET00729 | |
| 0.019 | 0.177 | 0.041 | Glutamate (mGluR8) agonist | 0.041 0.02 DBMET00729 | DBMET00729 | |
| 0.02 | 0.182 | 0.103 | Phosphofructokinase-1 inhibitor | 0.103 0.031 DBMET00729 | DBMET00729 | |
| 0.009 | 0.172 | 0.037 | Carnitine palmitoyltransferase 1 inhibitor | 0.037 0.02 DBMET00729 | DBMET00729 | |
| 0.088 | 0.252 | 0.163 | CF transmembrane conductance regulator agonist | 0.163 0.055 DBMET00729 | DBMET00729 | |
| 0.009 | 0.173 | 0.052 | Factor Xa inhibitor | 0.052 0.028 DBMET00729 | DBMET00729 | |
| 0.042 | 0.212 | 0.176 | HIV-1 integrase (Overall Integration) inhibitor | 0.176 0.017 DBMET00729 | DBMET00729 | |
| 0.088 | 0.26 | 0.128 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.128 0.121 DBMET00729 | DBMET00729 | |
| 0.008 | 0.181 | 0.035 | Carnitine palmitoyltransferase inhibitor | 0.035 0.021 DBMET00729 | DBMET00729 | |
| 0.017 | 0.191 | 0.079 | Alcohol oxidase inhibitor | 0.079 0.025 DBMET00729 | DBMET00729 | |
| 0.068 | 0.245 | 0.121 | Phospholipase A2 inhibitor | 0.121 0.116 DBMET00729 | DBMET00729 | |
| 0.036 | 0.214 | 0.086 | CDK2/cyclin A inhibitor | 0.086 0.072 DBMET00729 | DBMET00729 | |
| 0.019 | 0.196 | 0.122 | Biliverdin reductase inhibitor | 0.122 0.013 DBMET00729 | DBMET00729 | |
| 0.025 | 0.209 | 0.089 | Glutamate decarboxylase inhibitor | 0.089 0.036 DBMET00729 | DBMET00729 | |
| 0.016 | 0.201 | 0.068 | Argininosuccinate synthase inhibitor | 0.068 0.031 DBMET00729 | DBMET00729 | |
| 0.01 | 0.214 | 0.051 | Ornithine carbamoyltransferase inhibitor | 0.051 0.038 DBMET00729 | DBMET00729 | |
| 0.021 | 0.234 | 0.077 | CC chemokine receptor antagonist | 0.077 0.054 DBMET00729 | DBMET00729 | |
| 0.049 | 0.266 | 0.098 | D-Ala-D-Ala ligase inhibitor | 0.098 0.031 DBMET00729 | DBMET00729 | |
| 0.026 | 0.247 | 0.075 | Purinergic P2X1 antagonist | 0.075 0.028 DBMET00729 | DBMET00729 | |
| 0.031 | 0.255 | 0.134 | Aminopeptidase B inhibitor | 0.134 0.045 DBMET00729 | DBMET00729 | |
| 0.04 | 0.264 | 0.072 | Vanilloid 4 agonist | 0.072 0.059 DBMET00729 | DBMET00729 | |
| 0.01 | 0.236 | 0.045 | NMDA 2A receptor antagonist | 0.045 0.042 DBMET00729 | DBMET00729 | |
| 0.02 | 0.25 | 0.044 | Glutamate (mGluR4) antagonist | 0.044 0.029 DBMET00729 | DBMET00729 | |
| 0.033 | 0.268 | 0.13 | Creatine kinase inhibitor | 0.13 0.034 DBMET00729 | DBMET00729 | |
| 0.041 | 0.284 | 0.104 | Phosphodiesterase 7B inhibitor | 0.104 0.052 DBMET00729 | DBMET00729 | |
| 0.036 | 0.281 | 0.08 | Glutathione S-transferase inhibitor | 0.08 0.061 DBMET00729 | DBMET00729 | |
| 0.053 | 0.304 | 0.159 | Cell wall synthesis inhibitor | 0.159 0.058 DBMET00729 | DBMET00729 | |
| 0.013 | 0.269 | 0.098 | AMPA 4 receptor antagonist | 0.098 0.005 DBMET00729 | DBMET00729 | |
| 0.03 | 0.286 | 0.135 | Cyclin-dependent kinase 9 inhibitor | 0.135 0.039 DBMET00729 | DBMET00729 | |
| 0.005 | 0.267 | 0.037 | Kainate receptor 2 antagonist | 0.037 0.024 DBMET00729 | DBMET00729 | |
| 0.11 | 0.375 | 0.253 | Antibacterial | 0.253 0.174 DBMET00729 | DBMET00729 | |
| 0.046 | 0.311 | 0.101 | DOPA decarboxylase inhibitor | 0.101 0.074 DBMET00729 | DBMET00729 | |
| 0.029 | 0.295 | 0.166 | MAP kinase 8 inhibitor | 0.166 0.024 DBMET00729 | DBMET00729 | |
| 0.033 | 0.304 | 0.174 | MAP kinase kinase inhibitor | 0.174 0.039 DBMET00729 | DBMET00729 | |
| 0.057 | 0.332 | 0.144 | Death-associated protein kinase 3 inhibitor | 0.144 0.131 DBMET00729 | DBMET00729 | |
| 0.036 | 0.313 | 0.126 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.126 0.109 DBMET00729 | DBMET00729 | |
| 0.015 | 0.298 | 0.05 | Aconitate hydratase inhibitor | 0.05 0.038 DBMET00729 | DBMET00729 | |
| 0.018 | 0.307 | 0.133 | Protein kinase (CK2) alpha inhibitor | 0.133 0.053 DBMET00729 | DBMET00729 | |
| 0.009 | 0.298 | 0.059 | Glutamate (mGluR3) antagonist | 0.059 0.009 DBMET00729 | DBMET00729 | |
| 0.019 | 0.311 | 0.071 | I kappa B kinase 2 inhibitor | 0.071 0.031 DBMET00729 | DBMET00729 | |
| 0.029 | 0.322 | 0.124 | Cystathionine beta-synthase inhibitor | 0.124 0.055 DBMET00729 | DBMET00729 | |
| 0.017 | 0.315 | 0.108 | Protein kinase (CK2) inhibitor | 0.108 0.057 DBMET00729 | DBMET00729 | |
| 0.023 | 0.322 | 0.114 | I kappa B kinase inhibitor | 0.114 0.029 DBMET00729 | DBMET00729 | |
| 0.037 | 0.347 | 0.082 | MDM2 inhibitor | 0.082 0.018 DBMET00729 | DBMET00729 | |
| 0.132 | 0.448 | 0.282 | 5 Hydroxytryptamine release inhibitor | 0.282 0.186 DBMET00729 | DBMET00729 | |
| 0.043 | 0.362 | 0.173 | Interleukin 8 antagonist | 0.173 0.022 DBMET00729 | DBMET00729 | |
| 0.093 | 0.425 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 DBMET00729 | DBMET00729 | |
| 0.039 | 0.387 | 0.096 | Phosphodiesterase 6D inhibitor | 0.096 0.061 DBMET00729 | DBMET00729 | |
| 0.067 | 0.419 | 0.136 | Sphingosine 1-phosphate receptor 5 antagonist | 0.136 0.087 DBMET00729 | DBMET00729 | |
| 0.027 | 0.384 | 0.073 | Glutamate (mGluR6) antagonist | 0.073 0.034 DBMET00729 | DBMET00729 | |
| 0.063 | 0.423 | 0.191 | DNA synthesis inhibitor | 0.191 0.137 DBMET00729 | DBMET00729 | |
| 0.11 | 0.478 | 0.225 | 5 Hydroxytryptamine uptake stimulant | 0.225 0.11 DBMET00729 | DBMET00729 | |
| 0.064 | 0.433 | 0.267 | Superoxide dismutase inhibitor | 0.267 0.065 DBMET00729 | DBMET00729 | |
| 0.026 | 0.399 | 0.13 | MAP kinase kinase 1 inhibitor | 0.13 0.027 DBMET00729 | DBMET00729 | |
| 0.015 | 0.398 | 0.079 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.038 DBMET00729 | DBMET00729 | |
| 0.026 | 0.421 | 0.243 | Anesthetic general | 0.243 0.053 DBMET00729 | DBMET00729 | |
| 0.036 | 0.445 | 0.171 | Peroxidase inhibitor | 0.171 0.068 DBMET00729 | DBMET00729 | |
| 0.026 | 0.452 | 0.113 | Cathepsin H inhibitor | 0.113 0.085 DBMET00729 | DBMET00729 | |
| 0.065 | 0.498 | 0.242 | Histamine release inhibitor | 0.242 0.161 DBMET00729 | DBMET00729 | |
| 0.019 | 0.521 | 0.088 | GABA C receptor rho-1 antagonist | 0.088 0.081 DBMET00729 | DBMET00729 | |
| 0.015 | 0.521 | 0.103 | GABA C receptor antagonist | 0.103 0.073 DBMET00729 | DBMET00729 | |
| 0.049 | 0.634 | 0.138 | Lipocortins synthesis antagonist | 0.138 0.125 DBMET00729 | DBMET00729 | |
| 0.049 | 0.656 | 0.229 | GABA C receptor rho-3 antagonist | 0.229 0.174 DBMET00729 | DBMET00729 | |
| 0.064 | 0.71 | 0.2 | Interleukin 2 agonist | 0.2 0.19 DBMET00729 | DBMET00729 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |